Trial intelligence / Profile preview

Autologous Adipose-derived MSCs for Gingival Recession

NCT04434794Phase 2Completed

Start
Jan 2018
Primary completion
Dec 2019
Modality
Stem Cell Therapies
Countries
1
01

Overview

A Phase 2 trial of autologous adipose-derived mesenchymal stromal cells in gingival recession. Started Jan 2018; status: completed.

02

Drugs

autologous adipose-derived mesenchymal stromal cells
03

Conditions

gingival recession

Beyond the preview

Go deeper on NCT04434794.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04434794.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call